Maciej Masłyk

1.5k total citations
64 papers, 1.2k citations indexed

About

Maciej Masłyk is a scholar working on Molecular Biology, Genetics and Organic Chemistry. According to data from OpenAlex, Maciej Masłyk has authored 64 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 17 papers in Genetics and 16 papers in Organic Chemistry. Recurrent topics in Maciej Masłyk's work include Estrogen and related hormone effects (16 papers), Protein Kinase Regulation and GTPase Signaling (10 papers) and Bioactive Compounds and Antitumor Agents (8 papers). Maciej Masłyk is often cited by papers focused on Estrogen and related hormone effects (16 papers), Protein Kinase Regulation and GTPase Signaling (10 papers) and Bioactive Compounds and Antitumor Agents (8 papers). Maciej Masłyk collaborates with scholars based in Poland, South Korea and Spain. Maciej Masłyk's co-authors include Konrad Kubiński, Monika Janeczko, Palanisamy Ravichandiran, Dong Jin Yoo, Anna Boguszewska‐Czubara, Ae Rhan Kim, Antony Paulraj Bella, J. Princy Merlin, Myung‐Kwan Han and Byung‐Hyun Park and has published in prestigious journals such as Analytical Chemistry, Journal of Hazardous Materials and Scientific Reports.

In The Last Decade

Maciej Masłyk

62 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maciej Masłyk Poland 19 511 329 292 238 135 64 1.2k
Jacek W. Morzycki Poland 23 964 1.9× 701 2.1× 102 0.3× 128 0.5× 62 0.5× 154 1.8k
Pavel Drašar Czechia 20 738 1.4× 393 1.2× 215 0.7× 286 1.2× 46 0.3× 158 1.5k
Xiaojie Jin China 22 766 1.5× 346 1.1× 301 1.0× 281 1.2× 43 0.3× 87 1.6k
Piotr Cmoch Poland 22 617 1.2× 917 2.8× 218 0.7× 179 0.8× 50 0.4× 111 1.5k
Mohamed Farès Egypt 23 668 1.3× 980 3.0× 306 1.0× 225 0.9× 70 0.5× 50 1.6k
Huacan Song China 27 537 1.1× 897 2.7× 101 0.3× 111 0.5× 57 0.4× 57 1.7k
Chunfang Gan China 19 487 1.0× 475 1.4× 52 0.2× 75 0.3× 116 0.9× 80 1.1k
Libing Yu United States 21 531 1.0× 1.1k 3.3× 86 0.3× 195 0.8× 29 0.2× 60 1.6k
Randy M. Wadkins United States 29 1.3k 2.6× 465 1.4× 66 0.2× 102 0.4× 107 0.8× 58 2.1k

Countries citing papers authored by Maciej Masłyk

Since Specialization
Citations

This map shows the geographic impact of Maciej Masłyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maciej Masłyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maciej Masłyk more than expected).

Fields of papers citing papers by Maciej Masłyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maciej Masłyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maciej Masłyk. The network helps show where Maciej Masłyk may publish in the future.

Co-authorship network of co-authors of Maciej Masłyk

This figure shows the co-authorship network connecting the top 25 collaborators of Maciej Masłyk. A scholar is included among the top collaborators of Maciej Masłyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maciej Masłyk. Maciej Masłyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masłyk, Maciej, et al.. (2025). Understanding Endometriosis: A Broad Review of Its Causes, Management, and Impact. International Journal of Molecular Sciences. 26(18). 8878–8878. 1 indexed citations
2.
Demkowicz, Sebastian, Janusz Rachoń, Maciej Masłyk, et al.. (2025). Novel nonsteroidal steroid sulfatase inhibitors containing glutamic acid unit. European Journal of Medicinal Chemistry. 291. 117627–117627.
3.
Ravichandiran, Palanisamy, Nikhil Maroli, Konrad Kubiński, et al.. (2024). In Vitro and In Vivo Biological Evaluation of Novel 1,4‐Naphthoquinone Derivatives as Potential Anticancer Agents. ChemMedChem. 19(24). e202400495–e202400495. 2 indexed citations
4.
Nowacka-Jechalke, Natalia, Konrad Kubiński, Maciej Masłyk, et al.. (2023). Crude Polysaccharides from Wild-Growing Armillaria mellea—Chemical Composition and Antidiabetic, Anti-Inflammatory, Antioxidant, and Antiproliferative Potential. Applied Sciences. 13(6). 3853–3853. 8 indexed citations
5.
Kubiński, Konrad, Monika Janeczko, Maciej Masłyk, et al.. (2023). Silver Is Not Equal to Silver: Synthesis and Evaluation of Silver Nanoparticles with Low Biological Activity, and Their Incorporation into C12Alanine-Based Hydrogel. Molecules. 28(3). 1194–1194. 8 indexed citations
6.
Daśko, Mateusz, Janusz Rachoń, Witold Kozak, et al.. (2022). Development of Sulfamoylated 4-(1-Phenyl-1H-1,2,3-triazol-4-yl)phenol Derivatives as Potent Steroid Sulfatase Inhibitors for Efficient Treatment of Breast Cancer. Journal of Medicinal Chemistry. 65(6). 5044–5056. 11 indexed citations
7.
Radzikowska-Büchner, Elżbieta, Paulina Wdowiak, Joanna Kozak, et al.. (2022). MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents—A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives. International Journal of Molecular Sciences. 23(5). 2745–2745. 18 indexed citations
9.
Golczyk, Hieronim, Eva Hřibová, Jaroslav Doležel, et al.. (2022). Migration of repetitive DNAs during evolution of the permanent translocation heterozygosity in the oyster plant (Tradescantia section Rhoeo). Chromosoma. 131(3). 163–173. 1 indexed citations
10.
Łapiński, Andrzej, Oleg M. Demchuk, Konrad Kubiński, et al.. (2021). New Supramolecular Drug Carriers: The Study of Organogel Conjugated Gold Nanoparticles. Molecules. 26(24). 7462–7462. 5 indexed citations
12.
Daśko, Mateusz, et al.. (2020). New potent steroid sulphatase inhibitors based on 6-(1-phenyl-1H-1,2,3-triazol-4-yl)naphthalen-2-yl sulphamate derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 239–248. 8 indexed citations
13.
Olech, Marta, Natalia Nowacka-Jechalke, Maciej Masłyk, et al.. (2019). Polysaccharide-Rich Fractions from Rosa rugosa Thunb.—Composition and Chemopreventive Potential. Molecules. 24(7). 1354–1354. 35 indexed citations
14.
Masłyk, Maciej, Monika Janeczko, Małgorzata Tokarska-Rodak, et al.. (2019). The Anti-Candida albicans Agent 4-AN Inhibits Multiple Protein Kinases. Molecules. 24(1). 153–153. 6 indexed citations
15.
Janeczko, Monika, et al.. (2018). Synthesis and Antimicrobial Activity of 4-Substituted 1,2,3-Triazole-Coumarin Derivatives. Molecules. 23(1). 199–199. 84 indexed citations
16.
Masłyk, Maciej, et al.. (2017). CX-4945: the protein kinase CK2 inhibitor and anti-cancer drug shows anti-fungal activity. Molecular and Cellular Biochemistry. 435(1-2). 193–196. 14 indexed citations
17.
Janeczko, Monika, Maciej Masłyk, Konrad Kubiński, & Hieronim Golczyk. (2017). Emodin, a natural inhibitor of protein kinase CK2, suppresses growth, hyphal development, and biofilm formation of Candida albicans. Yeast. 34(6). 253–265. 65 indexed citations
18.
Kubiński, Konrad & Maciej Masłyk. (2017). The Link between Protein Kinase CK2 and Atypical Kinase Rio1. Pharmaceuticals. 10(1). 21–21. 5 indexed citations
19.
Masłyk, Maciej, José María Zapico, Claire Coderch, et al.. (2015). Synthesis, biological activity and structural study of new benzotriazole-based protein kinase CK2 inhibitors. RSC Advances. 5(89). 72482–72494. 21 indexed citations
20.
Frączyk, Tomasz, Konrad Kubiński, Maciej Masłyk, et al.. (2010). Phosphorylation of thymidylate synthase from various sources by human protein kinase CK2 and its catalytic subunits. Bioorganic Chemistry. 38(3). 124–131. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026